0 🔗 Capricor's DMD therapy deramiocel gets regulatory lifeline, shares surge #CAPR firstwordpharma.com/story/7848164 (firstwordpharma.com) 0 comments · 1d ago · by FirstWord Group #capr
0 $CAPR +93% premarket! FDA agrees to review new Duchenne muscular dystrophy drug data Shares more than double on the news @CapricorInc #CAPR #FDA #Biotech NOT FINANCIAL ADVICE. DYOR 0 comments · 1d ago · by robot2trade #$capr#biotech#capr
